Immediate Impact

5 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
2 intermediate papers

Works of Atul D. Jain being referenced

Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
2019

Author Peers

Author Last Decade Papers Cites
Atul D. Jain 505 114 124 16 686
Jean‐François Gaussin 341 134 113 10 582
Vidula Sukhatme 401 60 183 18 829
Akihiro Hashimoto 325 116 205 32 607
Ying-Qing Wang 517 89 84 29 748
Charlotte Dubois 296 57 71 21 744
Kathleen M. Gillooly 257 145 164 17 768
Harlan W. Cole 188 153 160 17 735
Tracy Ediger 326 24 154 16 764
Yali Deng 473 233 231 13 773
Paola Picardi 351 24 120 16 715

All Works

Loading papers...

Rankless by CCL
2026